Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies

(2013) A. A. Zasada et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Multiplex Cytokine Concentration Measurement: How Much Do the Medium and Handling Matter?

(2013) Luke Parkitny et al.   MEDIATORS OF INFLAMMATION

Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease

(2012) Holly D. Soares   ARCHIVES OF NEUROLOGY

Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer Disease

(2012) John M. Ringman et al.   ARCHIVES OF NEUROLOGY

Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease

(2012) James D. Doecke   ARCHIVES OF NEUROLOGY

Relationship between Inflammatory Mediators, A? Levels and ApoE Genotype in Alzheimer Disease

(2012) M. Reale et al.   Current Alzheimer Research

Increased systemic inflammatory interleukin-1ß and interleukin-6 during agitation as predictors of Alzheimer's disease

(2012) T. Honma et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness

(2012) Rui Chen et al.   JOURNAL OF NEUROIMMUNOLOGY

The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis

(2012) A. Koyama et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline

(2012) Johannes vom Berg et al.   NATURE MEDICINE

Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship

(2012) Brianne Magouirk Bettcher et al.   NEUROCASE

Neuroinflammation and Synaptic Loss

(2012) Jagadeesh S. Rao et al.   NEUROCHEMICAL RESEARCH

Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease

(2012) Yangtong Han et al.   NEUROSCIENCE LETTERS

CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

(2012) Karin Westin et al.   PLoS One

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease

(2012) Maria Björkqvist et al.   PLoS One

Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset

(2012) Daniel Johnstone et al.   PLoS One

Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls

(2011) Daniel A. Llano et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Chemokines in CSF of Alzheimer's disease patients

(2011) Jôice Dias Corrêa et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration

(2011) Massimiliano M. Corsi et al.   BIOGERONTOLOGY

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease

(2011) Sam-Moon Kim et al.   BMC Neurology

Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples

(2011) Maartje I. Kester et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Role of Interleukin 6 and Alpha-Globulins in Differentiating Alzheimer and Vascular Dementias

(2011) Azza A. Helmy et al.   Neurodegenerative Diseases

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

(2011) Rebecca Craig-Schapiro et al.   PLoS One

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

(2010) J. Kálmán et al.   ACTA NEUROLOGICA SCANDINAVICA

Contribution of systemic inflammation to chronic neurodegeneration

(2010) V. Hugh Perry   ACTA NEUROPATHOLOGICA

A Meta-Analysis of Cytokines in Alzheimer's Disease

(2010) Walter Swardfager et al.   BIOLOGICAL PSYCHIATRY

Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels

(2010) F. Angelucci et al.   Current Alzheimer Research

Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer’s Disease Cases

(2010) Sid E. O’Bryant et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients

(2010) Christoph Laske et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer’s disease patients

(2010) B. Juraskova et al.   Journal of Nutrition Health & Aging

Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease

(2010) Piet Eikelenboom et al.   Neurodegenerative Diseases

Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels

(2009) Holly D. Soares et al.   Annals of the New York Academy of Sciences

Peripheral Cytokines and Chemokines in Alzheimer’s Disease

(2009) Kang Soo Lee et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment

(2009) Orestes Vicente Forlenza et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Multiplex Analysis of Cytokines in the Serum and Cerebrospinal Fluid of Patients With Alzheimer's Disease by Color-Coded Bead Technology

(2009) Chulhee Choi et al.   Journal of Clinical Neurology

Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease

(2009) Josef Marksteiner et al.   NEUROBIOLOGY OF AGING

Systemic inflammation and disease progression in Alzheimer disease

(2009) C. Holmes et al.   NEUROLOGY

Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects

(2009) Ge Li et al.   PLoS One

CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease

(2009) S. D Mulder et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease

(2008) Joseph J. Locascio et al.   ARCHIVES OF NEUROLOGY

Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study

(2008) Stefan Kassner et al.   Current Alzheimer Research

Diagnostic utility of APOE, soluble CD40, CD40L, and Aβ1–40 levels in plasma in Alzheimer’s disease

(2008) Ghania Ait-ghezala et al.   CYTOKINE

Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment

(2008) Kang Soo Lee et al.   IMMUNOLOGY LETTERS

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease

(2008) Paloma Bermejo et al.   IMMUNOLOGY LETTERS

Cytokines in Alzheimer's Disease and Vascular Dementia

(2008) P. Angelopoulos et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

(2008) D. Galimberti et al.   JOURNAL OF NEUROLOGY

Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia

(2008) G. Zuliani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment

(2008) Peder Buchhave et al.   NEUROBIOLOGY OF AGING

Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease

(2008) Peder Buchhave et al.   NEUROSCIENCE LETTERS

Systemic immune aberrations in Alzheimer's disease patients

(2007) Konstantinos Bonotis et al.   JOURNAL OF NEUROIMMUNOLOGY

Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients

(2007) Johanna Ojala et al.   NEUROBIOLOGY OF AGING